Pete Anevski is the CEO of Progyny, a healthcare company focused on fertility benefits. He took over this role on January 1, 2022, after serving as the President and COO since 2019, and before that, he was the CFO. His...

Pete Anevski is the CEO of Progyny, a healthcare company focused on fertility benefits. He took over this role on January 1, 2022, after serving as the President and COO since 2019, and before that, he was the CFO. His career in healthcare began at WebMD, where he spent several years, eventually rising to a key financial position. In 2023, Pete's total compensation reached over $1.1 million, which includes a salary of $500,000 and a substantial bonus partly linked to the company's performance. An interesting fact is that he was granted 1 million stock options when he became CEO, which emphasizes a performance-focused culture at Progyny that aligns the executives' success with shareholders' success. Additionally, under his leadership, the company's performance metrics like revenue growth and client retention have been notable. In terms of stock performance, Pete's personal holdings in Progyny reflect a significant commitment to the company's future, showing he has a vested interest in its success. With a leadership style that blends operation experience and financial insight, Anevski aims to keep progressing in the healthcare sector.